Zhonghua Er Ke Za Zhi. 2012 May;50(5):336-42.
To study the effects of human milk fortification on growth and safety in premature infants in China during hospital stay.
A prospective controlled study was conducted in 4 tertiary hospitals in Beijing and Shanghai, premature infants born from Nov. 2009 to Mar. 2011 were included according to certain enrollment criteria. Premature infants were divided into two groups: fortified human milk group, i.e., FHM group who were fed with human milk over 50 percent during hospital stays, preterm formula was used for those whose mothers did not have enough milk, and preterm formula group as control who were fed fully with preterm formula. The enteral and parenteral nutritional intakes, complications and growth were compared between the two groups.
Among the 125 cases included, 62 were in the HMF group, and 63 were in the preterm formula group. Birth weight of HMF group (1429.1 ± 209.0) g was lower than that of the preterm formula group (1514.0 ± 210.5) g, there was no significant difference in gestational age, head circumference, length at birth, and correction gestational age at discharge, weight, head circumference and length at discharge, time for regaining birth weight, the mean daily protein, length of hospitalization between the two groups (P > 0.05). There was also no significant difference in the days for achieving total energy intake of 120 cal/(kg·d) and 150 ml/(kg·d) through enteral feeding between the two groups. The velocity of gaining weight, head circumference, and length after regaining birth weight 0.7 vs. 0.6 cm/W;1.1 vs. 0.9 cm/W were similar between the 2 groups. The biochemical parameters were similar at birth, but the serum urea nitrogen, prealbumin levels in FHM group were lower than those in the control group [(2.20 ± 1.17) vs. (2.66 ± 1.21) mmol/L (P = 0.036); (91.33 ± 21.21) vs. (107.0 ± 33.58) mg/L (P = 0.003)], while the calcium levels were higher than those of the control group [(2.48 ± 0.21) vs. (2.39 ± 0.15) mmol/L, P = 0.016]. Serum alkaline phosphatase and phosphor showed no significant difference [(2.01 ± 0.36) vs. (2.02 ± 0.42) mmol/L; (311.68 ± 142) vs. (284.67 ± 111) U/L]. Nosocomial infection in the FHM group was significantly lower than that in the control group [10 cases (16.1%) vs. 20 cases (31.7%), P = 0.021], there was no significant difference in incidence of feeding intolerance, necrotizing enterocolitis (NEC) between the two groups. The frequency and lasting time of feeding intolerance was obviously less in the FHM group than that in the control group.
Premature infants fed with fortified human milk showed similar growth pattern to those fed with preterm formula during hospital stay. FHM may decrease the incidence of nosocomial infection and feeding intolerance.
研究人乳强化剂对我国早产儿住院期间生长及安全性的影响。
在北京和上海的4家三级医院进行一项前瞻性对照研究,根据一定的纳入标准纳入2009年11月至2011年3月出生的早产儿。早产儿分为两组:强化人乳组,即FHM组,住院期间50%以上时间喂养人乳,母亲乳汁不足者使用早产儿配方奶;早产儿配方奶组作为对照组,完全喂养早产儿配方奶。比较两组的肠内和肠外营养摄入、并发症及生长情况。
纳入的125例中,FHM组62例,早产儿配方奶组63例。FHM组出生体重(1429.1±209.0)g低于早产儿配方奶组(1514.0±210.5)g,两组在胎龄、头围、出生时身长、出院时矫正胎龄、体重、头围、身长、恢复出生体重时间、每日平均蛋白摄入量、住院时间方面差异无统计学意义(P>0.05)。两组通过肠内喂养达到总能量摄入120 cal/(kg·d)和150 ml/(kg·d)的天数差异无统计学意义。两组恢复出生体重后的体重、头围和身长增长速度相似(0.7 vs. 0.6 cm/周;1.1 vs. 0.9 cm/周)。出生时生化指标相似,但FHM组血清尿素氮、前白蛋白水平低于对照组[(2.20±1.17)vs.(2.66±1.21)mmol/L(P=0.036);(91.33±21.21)vs.(107.0±33.58)mg/L(P=0.003)],而钙水平高于对照组[(2.48±0.21)vs.(2.39±0.15)mmol/L,P=0.016]。血清碱性磷酸酶和磷差异无统计学意义[(2.01±0.36)vs.(2.02±0.42)mmol/L;(311.68±142)vs.(284.67±111)U/L]。FHM组医院感染明显低于对照组[10例(16.1%)vs. 20例(31.7%),P=0.021],两组喂养不耐受、坏死性小肠结肠炎(NEC)发生率差异无统计学意义。FHM组喂养不耐受的频率和持续时间明显少于对照组。
住院期间,喂养强化人乳的早产儿与喂养早产儿配方奶的早产儿生长模式相似。强化人乳可能降低医院感染和喂养不耐受的发生率。